“The ‘A+’ rating reflects our assessment of Memorial Hermann’s market-leading position, consistent operating performance in fiscal year 2016 year-to-date, continued improvement to unrestricted reserves and key liquidity ratios; and strategic footprint in the Texas Medical Center and surrounding Houston communities,” said Kevin Holloran.
The outlook is positive, reflecting S&P’s expectation that Memorial Hermann’s financial performance will remain consistent.
More articles on healthcare finance:
3 obvious and not-so-obvious reasons hospitals close
CMS gives initial OK for hospital outpatient billing of the Verax PGD test
New campaign in Kansas targets Medicaid expansion
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
